Evidence map›Paper›PMID 38624245›Full record

ReviewPhysiology (Bethesda, Md.)2024

A New Phase for WNK Kinase Signaling Complexes as Biomolecular Condensates.

Cary R Boyd-Shiwarski, Daniel J Shiwarski, Arohan R Subramanya

Open access · greenAbstract readReview
In one paragraph

Review in Physiology (Bethesda, Md.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. The evolving concepts of KS-WNK1 effect on NCC activity.American journal of physiology. Renal physiology · 2025
    Review
  6. Familial Hyperkalemic Hypertension.Comprehensive Physiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Cary R Boyd-ShiwarskiRenal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.ORCID 0000-0002-2350-3052
Daniel J ShiwarskiVascular Medicine Institute, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.ORCID 0000-0001-6978-303X
Arohan R SubramanyaRenal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.ORCID 0000-0002-2609-7643
University of Pittsburgh · US

Funding

Single Nephron and MetabolomicsP30DK079307 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLEYMAN, THOMAS R · 2008 to 2022
$13.4M
Resource Development CoreU54DK137329 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Thomas R Kleyman · 2023 to 2026
$4.8M
Control of the Renal WNK Signaling Pathway by Phase TransitionsR01DK098145 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AYLIN RACHEL RODAN, AROHAN R SUBRAMANYA · 2014 to 2026
$4.2M
Regulation of Renal WNK Signaling in Intercalated CellsR01DK119252 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SUBRAMANYA, AROHAN R · 2019 to 2023
$2.0M
The function of kidney specific (KS)-WNK1 condensates during potassium stressK08DK118211 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BOYD-SHIWARSKI, CARY RAGAN · 2018 to 2022
$923k
Development of a Collagen-based 3D Bioprinted Microfluidic Platform for Vascular Tissue Engineering and Disease ModelingR00HL155777 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHIWARSKI, DANIEL J · 2023 to 2025
$747k
Leica Stellaris Confocal for Kidney Imaging CoreS10OD028596 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI APODACA, GERARD L · 2021 to 2021
$596k
Integrated perfusion and confocal imaging systemS10OD021627 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WEISZ, ORA A · 2016 to 2016
$479k
Establishing new model systems to study low potassium induced kidney injuryR03DK138215 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BOYD-SHIWARSKI, CARY RAGAN · 2024 to 2025
$222k
NHLBI NIH HHS R00 HL155777NIDDK NIH HHS K08 DK118211NIDDK NIH HHS P30 DK079307NIDDK NIH HHS R01 DK098145NIDDK NIH HHS R01 DK119252NIDDK NIH HHS R03 DK138215NIDDK NIH HHS U54 DK137329NIH HHS S10 OD021627NIH HHS S10 OD028596
6 · The paper itself

Abstract

The purpose of this review is to highlight transformative advances that have been made in the field of biomolecular condensates, with special emphasis on condensate material properties, physiology, and kinases, using the With-No-Lysine (WNK) kinases as a prototypical example. To convey how WNK kinases illustrate important concepts for biomolecular condensates, we start with a brief history, focus on defining features of biomolecular condensates, and delve into some examples of how condensates are implicated in cellular physiology (and pathophysiology). We then highlight how WNK kinases, through the action of "WNK droplets" that ubiquitously regulate intracellular volume and kidney-specific "WNK bodies" that are implicated in distal tubule salt reabsorption and potassium homeostasis, exemplify many of the defining features of condensates. Finally, this review addresses the controversies within this emerging field and questions to address.

Indexed as

Signal TransductionWNK Lysine-Deficient Protein Kinase 1AnimalsHumansProtein Serine-Threonine KinasesProtein Serine-Threonine KinasesWNK Lysine-Deficient Protein Kinase 1biomolecular condensatesphase separationWNK bodiesWNK dropletsWNK kinases

Identifiers

PMID38624245
PMCPMC11460533
OpenAlexW4394836728

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.